Anatomical Feasibility of Multibranched Off-the-shelf Endografts for Thoracoabdominal and Para-renal Aortic Aneurysms (TAMBE Study)
NCT ID: NCT03213795
Last Updated: 2020-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
562 participants
OBSERVATIONAL
2017-04-12
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anatomical Feasibility of the Off-the-shelf E-nside Multibranch Stent Graft System for Thoracoabdominal and Para-renal Aortic Aneurysms.(E-nside Study)
NCT03959670
Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms
NCT01328197
Registry in Patients With Thoracoabdominal Aneurysms
NCT03295682
MuLtibranchEd Graft for OPen RepAir of ThoRacoabdominal Aneurysms
NCT04430114
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
NCT02323581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Materials and methods:
The investigators review retrospectively the pre-operative contrast-enhanced computed tomography scans (CTA), stored in the hospital PACS, of the 562 patients treated at the San Raffaele Hospital's Vascular Surgery Unit, between January 2007 and January 2017 by means of open aortic aneurysm repair. All patients involved in the study have already signed informed consent for data collection and analysis at hospital admission.
Inclusion criteria:
• patient who underwent treatment of thoracoabdominal or para-renal aortic aneurysm at San Raffaele Hospital in between January 2007 and January 2017.
Exclusion criteria:
• incomplete or inappropriate imaging quality defined as pre-operative CTAs with slice thickness \>1-mm.
All preoperative CTAs with 1-mm slice thickness will be included in the study and analyzed on the dedicated workstation with OsiriX software (Pixmeo sarl, Bernex, Switzerland) currently employed in the Unit for imaging assessment.
Sensitive patient information will not be available during data analysis.
Vascular access will be evaluated according to the following inclusion criteria:
1. femoral and iliac artery diameter ≥8mm (24Fr) on one side and ≥5mm (16Fr) on the contralateral side, without severe calcification or tortuosity;
2. at least one patent vessel for anterograde branch cannulation (branchial/axillary/subclavian artery) with diameter ≥3mm.
The proportion of patients excluded due to inadequate vascular accesses will be reported in the final results together with diameter of the smallest access vessels determining the exclusion.
The selected patient sample will be subdivided in three groups:
1. extensive TAAA: including Crawford extent I and II TAAA;
2. Crawford extent III TAAA;
3. supra-renal aortic aneurysms: including Crawford extent IV TAAA and para-renal abdominal aortic aneurysms.
The latest 100 consecutive cases per group will be subsequently studied in order to assess the feasibility of an off-the-shelf endovascular approach.
Multi-planar and curved reconstruction of each patient CTA will be analyzed and the following measurements recorded using the top of the ostium of the celiac trunk as reference point:
1. patency of the target vessels (CT, SMA, LRA and RRA);
2. presence of accessory renal arteries or independent origin of celiac trunk branches;
3. inner diameter of the target vessels;
4. target vessels with aberrant or early branching, aneurysm or dissection, with \<15mm of healthy artery for bridging stent placement;
5. radial orientation of the target vessels ("clock position", expressed in degrees);
6. orientation of the target vessels with respect to the longitudinal aortic axis (expressed in degrees);
7. distance to the top of the ostium of target vessels;
8. distance to aortic bifurcation and bilateral iliac bifurcation;
9. aneurysmatic involvement of common iliac arteries (max diameter \>20mm);
10. distance to proximal aneurysm neck (25mm of healthy aorta);
11. distance to left subclavian artery;
12. inner and outer diameter at proximal neck, at 1cm and 2cm above proximal neck, at aortic bifurcation, and at common iliac artery bilaterally;
13. residual aortic lumen at CT, SMA and renal arteries emergence.
The feasibility will be evaluated considering the patients and endografts characteristics and all the technical steps required for a proper endovascular aneurysm exclusion.
All the assessed variables will be prospectively recorded in a Microsoft Office Excel database.
The clinical study will be carried out according to the ethical principles of the Declaration of Helsinki and following the active regulations on observational studies.
Analysis:
The extracted data will be employed to feed three major lines of research:
1. to evaluate the anatomical suitability of the novel investigational Gore TAMBE (W.L. Gore \& Associates, Flagstaff, AZ, USA) multibranched off-the-shelf stent-graft for total endovascular management of thoracoabdominal and para-renal aortic aneurysms;
2. to evaluate the anatomical suitability, according to Instruction for Use and literature recommendations, of the commercially available Cook T-Branch (Cook Medical, Bloomington, IN, USA) multibranched off-the-shelf stent-graft for total endovascular management of thoracoabdominal and para-renal aortic aneurysms. This line of research will focus on the evaluation of the expected length of healthy aorta sacrificed to obtain appropriate proximal endograft sealing;
3. to compare the applicability of Gore TAMBE and Cook T-Branch endografts in TAAA of different extents and para-renal aneurysms.
The results of the three studies will be submitted for publication in peer-reviewed scientific journals focused on the field of vascular and endovascular surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS San Raffaele
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bertoglio Luca
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Raffaele Hospital
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chuter TA, Rapp JH, Hiramoto JS, Schneider DB, Howell B, Reilly LM. Endovascular treatment of thoracoabdominal aortic aneurysms. J Vasc Surg. 2008 Jan;47(1):6-16. doi: 10.1016/j.jvs.2007.08.032. Epub 2007 Nov 5.
Sobocinski J, d'Utra G, O'Brien N, Midulla M, Maurel B, Guillou M, Azzaoui R, Roeder B, Resch TA, Haulon S. Off-the-shelf fenestrated endografts: a realistic option for more than 70% of patients with juxtarenal aneurysms. J Endovasc Ther. 2012 Apr;19(2):165-72. doi: 10.1583/11-3772.1.
Cambiaghi T, Grandi A, Bilman V, Melissano G, Chiesa R, Bertoglio L. Anatomic feasibility of the investigational GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis (TAMBE), off-the-shelf multibranched endograft for the treatment of pararenal and thoracoabdominal aortic aneurysms. J Vasc Surg. 2021 Jan;73(1):22-30. doi: 10.1016/j.jvs.2020.03.056. Epub 2020 Apr 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TAMBE/39/OSR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.